JNJ-20788560

JNJ-20788560^[1]
Names
	IUPAC name 9-[(1S,5R)-8-Azabicyclo[3.2.1]octan-3-ylidene]-N,N-diethylxanthene-3-carboxamide
Identifiers
CAS Number	825649-28-3;
3D model (JSmol)	Interactive image;
ChemSpider	28189733;
PubChem CID	72710739;
	InChI InChI=1S/C25H28N2O2/c1-3-27(4-2)25(28)16-9-12-21-23(15-16)29-22-8-6-5-7-20(22)24(21)17-13-18-10-11-19(14-17)26-18/h5-9,12,15,18-19,26H,3-4,10-11,13-14H2,1-2H3/t18-,19+ Key: MISSUZBVOCUXTG-KDURUIRLSA-N;
	SMILES CCN(CC)C(=O)C1=CC2=C(C=C1)C(=C3CC4CCC(C3)N4)C5=CC=CC=C5O2;
Properties
Chemical formula	C25H28N2O2
Molar mass	388.511 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

JNJ-20788560 is a potent opioid drug selective for the delta opioid receptor.^[2]

Mechanism of action

It works by activating opioid receptors, but it is selective for the δ-opioid receptor. This selectivity allows this drug to have less side effects than opioids such as morphine.

Tests have revealed that JNJ-20788560 does not produce hypoventilation, tolerance, or physical dependence.^[3]

References

^ "9-(8-azabicyclo(3.2.1)oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide".
^ Codd, Ellen E.; Ma, Jianya; Zhang, Sui-Po; Stone, Dennis J.; Colburn, Raymond W.; Brandt, Michael R.; Chevalier, Kristen M.; Zhu, Yongxin; Peng, Sean; Cai, Chaozhong; Acton, Paul D.; Flores, Christopher M. (August 2010). "Ex vivo delta opioid receptor autoradiography: CNS receptor occupancy of two novel compounds over their antihyperalgesic dose range". Pharmacology, Biochemistry, and Behavior. 96 (2): 130–135. doi:10.1016/j.pbb.2010.04.020. ISSN 1873-5177. PMID 20438745. S2CID 5471813.
^ Codd, Ellen E.; Carson, John R.; Colburn, Raymond W.; Stone, Dennis J.; Van Besien, Christopher R.; Zhang, Sui-Po; Wade, Paul R.; Gallantine, Elizabeth L.; Meert, Theo F.; Molino, Lory; Pullan, Shirley; Razler, Christine M.; Dax, Scott L.; Flores, Christopher M. (April 2009). "JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependence". The Journal of Pharmacology and Experimental Therapeutics. 329 (1): 241–251. doi:10.1124/jpet.108.146969. ISSN 1521-0103. PMID 19151246. S2CID 15119165.

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

[1] "9-(8-azabicyclo(3.2.1)oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide".

[2] Codd, Ellen E.; Ma, Jianya; Zhang, Sui-Po; Stone, Dennis J.; Colburn, Raymond W.; Brandt, Michael R.; Chevalier, Kristen M.; Zhu, Yongxin; Peng, Sean; Cai, Chaozhong; Acton, Paul D.; Flores, Christopher M. (August 2010). "Ex vivo delta opioid receptor autoradiography: CNS receptor occupancy of two novel compounds over their antihyperalgesic dose range". Pharmacology, Biochemistry, and Behavior. 96 (2): 130–135. doi:10.1016/j.pbb.2010.04.020. ISSN 1873-5177. PMID 20438745. S2CID 5471813.

[3] Codd, Ellen E.; Carson, John R.; Colburn, Raymond W.; Stone, Dennis J.; Van Besien, Christopher R.; Zhang, Sui-Po; Wade, Paul R.; Gallantine, Elizabeth L.; Meert, Theo F.; Molino, Lory; Pullan, Shirley; Razler, Christine M.; Dax, Scott L.; Flores, Christopher M. (April 2009). "JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependence". The Journal of Pharmacology and Experimental Therapeutics. 329 (1): 241–251. doi:10.1124/jpet.108.146969. ISSN 1521-0103. PMID 19151246. S2CID 15119165.

[1]

[2]

[3]